Kennedy Disease, also known as Spinal Bulbar Muscular Atrophy (SBMA), is a progressive neuromuscular disorder caused by a polyglutamine expansion in the androgen receptor (AR) gene. This page examines the specific vulnerability of motor neurons in Kennedy Disease and the molecular mechanisms underlying their degeneration.
| Property | Value |
|---|---|
| Category | Motor Neurons |
| Location | Spinal cord anterior horn, brainstem motor nuclei |
| Cell Type | Lower motor neurons (alpha motor neurons) |
| Key Gene | AR (Androgen Receptor) — CAG repeat expansion |
| Inheritance | X-linked recessive |
| Onset | Typically 30-50 years of age |
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000100 | motor neuron |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000100 | motor neuron | Medium |
| Cell Ontology | CL:4042028 | immature neuron | Medium |
Motor neurons in the anterior horn of the spinal cord and brainstem nuclei are the primary efferent neurons controlling voluntary muscle movement. Their functions include:
Kennedy Disease results from a CAG trinucleotide repeat expansion in the first exon of the AR gene, encoding a polyglutamine (polyQ) tract in the androgen receptor protein[1].
| Feature | Normal | Kennedy Disease |
|---|---|---|
| CAG repeats | 10-36 | 38-62 |
| Protein length | PolyQ length ~10-36 | PolyQ 38-62 |
| AR function | Normal androgen binding | Toxic gain-of-function |
The expanded polyQ tract in the androgen receptor leads to:
| Pathway | Effect |
|---|---|
| Mitochondrial function | Reduced ATP production, increased ROS |
| Calcium homeostasis | Dysregulated Ca²⁺ signaling |
| Autophagy | Impaired protein clearance |
| Proteostasis | Aggregate accumulation |
| Axonal transport | Disrupted microtubule function |
Multiple animal models have been developed to study SBMA pathogenesis:
Key findings from models include:
| Approach | Mechanism | Status |
|---|---|---|
| ASO therapy | Knockdown of mutant AR mRNA | Preclinical |
| AR modulators | Partial antagonists (bicalutamide) | Clinical trials |
| Hsp90 inhibitors | Promote AR degradation | Preclinical |
| Autophagy inducers | Enhance protein clearance | Preclinical |
| Mitochondrial protectors | Improve energy metabolism | Preclinical |
The study of Motor Neurons In Kennedy Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
La Spada et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy (1991). 1991. ↩︎